We use cookies to make this site as useful as possible. Read our cookie policy or allow cookies.

Pharma companies caught breaking the law on the rise?

27 June 2014

Allegations of pharma companies caught breaking the law on the rise in recent years.

With multiple investigations looking into pharmaceutical giant GlaxoSmithKline’s (GSK) conduct, assistant editor at Governance + Compliance, Pooja Kondhia spoke to Tony Woodcock, head of regulatory litigation at law firm Stephenson Harwood, about why pharma companies breaking the law has increased in recent years.








Previous articles have looked at the allegations of misconduct surrounding GSK, such as bribery and market abuse, as well as Pfizer, although these are not the only companies to have been penalised.

 

 

Have your say

comments powered by Disqus

Advertisements


ICSA: The Governance Institute
Saffron House, 6-10 Kirby Street, London EC1N 8TS, United Kingdom